CTCTS could represent a valid treatment option for retained blood syndrome; nevertheless, caution is warranted due to cost-benefits and results confirmation from larger randomized studies.
Commentary: New technology impact on chest tube clotting after cardiac surgery. A possible paradigm shift? / Dokollari, Aleksander; Prifti, Edvin; Torregrossa, Gianluca; Bonacchi, Massimo. - In: JTCVS OPEN. - ISSN 2666-2736. - STAMPA. - (2022), pp. 1-2. [10.1016/j.xjon.2022.04.006]
Commentary: New technology impact on chest tube clotting after cardiac surgery. A possible paradigm shift?
Bonacchi, Massimo
2022
Abstract
CTCTS could represent a valid treatment option for retained blood syndrome; nevertheless, caution is warranted due to cost-benefits and results confirmation from larger randomized studies.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S2666273622001553-main.pdf
Accesso chiuso
Descrizione: full-text
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
114.85 kB
Formato
Adobe PDF
|
114.85 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
